Home Business & Economics

Business & Economics

SurVaxM. Photo Courtesy: 2019 Roswell Park.

Large Phase II Study to Investigate SurVaxM in Glioblastoma in China...

Peter Hofland, Ph.D -
Noona® software application is a smart, cloud-based patient-reported outcomes (PRO) solution. Through the capture and analysis of structured, real-time symptom information, Noona helps clinicians better manage patient symptoms and improve treatment outcomes. Noona is designed to support the everyday work of nurses and physicians in cancer care, helping to increase clinical efficiency and reduce workloads through comprehensive communications tools.

Michigan Oncology Quality Consortium Selects Varian to Support Transition to Value-Based...

Peter Hofland, Ph.D -

Paired RNA + DNA Tests for Hereditary Cancer Identifies more Patients...

Peter Hofland, Ph.D -

Cellectis + Lonza Sign cGMP Manufacturing Service Agreement for Allogeneic UCART...

Peter Hofland, Ph.D -
The Little Mermaid, Copenhagen,Denmark

Danish Biotech Develops Antibody-drug Conjugate for Treatment of Metastatic Soft Tissue...

Peter Hofland, Ph.D -

Research and Development for Rovalpituzumab Tesirine in Lung Cancer Discontinued

Peter Hofland, Ph.D -

NanoValent Receives Patent for Novel Targeted Polymerized Nanoparticles

Danielle Garcia -

Aquinox and Neoleukin Merge to Create Next Generation Immunotherapies

Peter Hofland, Ph.D -

FDA Approves Pfizer’s Biosimilar rituximab-pvvr for Certain Cancers and Autoimmune Conditions

Peter Hofland, Ph.D -
Medical equipment for blood analysis.

Liquid Biopsy Enables Widespread Screening and Personalized Treatment

Danielle Garcia -
123...8Page 1 of 8

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.